Danny Tagaloa

Danny Tagaloa is in Laboratory Operations for Octant. For over a decade, he led the Facilities group for Plexxikon Inc. and contributed to the success of two market drugs, Zelboraf and Pexidartinib. Danny spent part of his childhood in American Samoa and enjoys the outdoors to garden, camping, or going fishing. In his spare time, he loves spending time with his family, including his grandchildren.

View Board of DirectorsView Full TeamView Scientific Advisory Board